Drug intelligence / Profile preview

AOX2.0 serum

Development stage: Preclinical
Modality: Small Molecules
Administration: Topical

Overview

AOX2.0 serum is a topical antioxidant formulation composed of Vitamin C (ascorbic acid), Feverfew (*Tanacetum parthenium*), and Epigallocatechin gallate (EGCG). It is designed to provide dual-action protection against ultraviolet (UV) radiation-induced skin damage. The serum works by significantly reducing UV-induced lipid peroxidation in keratinocytes and fibroblasts and preserving epidermal barrier integrity. Research presented at the AAD 2026 meeting demonstrated that AOX2.0 maintains filaggrin expression and increases transepithelial electrical resistance (TEER) following oxidative stress, thereby supporting epidermal recovery and overall skin health.

Brand names: AOX2.0 serumAOX-2.0 serumAOX 2.0 serum
Other names: Antioxidant Serum

Beyond the preview

Go deeper on AOX2.0 serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AOX2.0 serum.

Explore the full profile